Parkinson’s Disease – BHV8000-301
Researching an investigational treatment to change the course of Parkinson’s Disease.
If you or a loved one has been diagnosed with early-stage Parkinson’s Disease, a clinical trial might be able to help. This trial is testing a drug against brain inflammation. We are enrolling people who have Parkinson’s disease with symptoms beginning within the last two years.
Participants Must:
- Be 40-85 years of age at the time of signing the informed consent form
- Have a documented diagnosis of Parkinson’s disease that started within 2 years of the first (screening) study visit.
- Not currently taking any medications for Parkinson’s disease.